CN101322731A - Capsule for protecting eye and lowering blood sugar - Google Patents
Capsule for protecting eye and lowering blood sugar Download PDFInfo
- Publication number
- CN101322731A CN101322731A CNA2007101127141A CN200710112714A CN101322731A CN 101322731 A CN101322731 A CN 101322731A CN A2007101127141 A CNA2007101127141 A CN A2007101127141A CN 200710112714 A CN200710112714 A CN 200710112714A CN 101322731 A CN101322731 A CN 101322731A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- diabetic retinopathy
- panacis quinquefolii
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a new medicine which can prevent diabetic retinopathy and has the effect of lowering blood sugar; the medicine is prepared by raw materials at least containing American ginseng and can be made into various dosage forms in pharmaceutics. The medicine is effective on ocular fundus retinopathy caused by diabetes mellitus and can relieve various clinical symptoms, and retard the worsening of the diseases.
Description
Technical field
The present invention relates to a kind of medicine of preventing and treating diabetic retinopathy, more particularly relating to a kind of is major-minorly to be the raw material treatment made from Chinese medicine and to delay the diabetic retinopathy progress and have the capsule preparations of blood sugar reducing function by Radix Panacis Quinquefolii.
Technical background
The diabetic retina is to become main ocular complications, clinical manifestation owing to what diabetes caused with the optical fundus retinopathy; The amphiblestroid pathologic in optical fundus changes, and causes that vision descends gradually, a kind of chronic progressive external pathological changes of final visual loss.
Western medicine is thought; Diabetes be because the caused a kind of chronic disease of human pancreatic islet dysfunction, along with prolongation, the glycemic control of the course of disease are undesirable.And it is ocular complications occurs, and obvious gradually.And the mechanism of diabetic retinopathy is not fully aware of.At present, medical circle approval has hemorheology and a microcirculation disturbance theory.Also have the mountain to plough pure path abnormal activation theory in addition, theory etc. that somatomedin synthesizes and release is lacked of proper care.
The clinical treatment diabetic retinopathy does not have specific medicament: mainly contain in early days: intestinal holds aspirin tablet, calcium dobesilate sheet, leads living bright, passs the invention sheet.The person of being in a bad way then need go optical fundus retina light and coagulate treatment, and severe patient needs operative treatment.And motherland's traditional medicine is then thought and should at first be treated diabetes, according to the Therapeutic Principle of the traditional Chinese medical science, treatment of disease must aim at its pathogenesis, specimen emergency, tonifying for the deficiency and eliminating for the excess, controls principles such as your adaptability in tactics.By treatment eight therapeutic methods prescription nourishing YIN and clearing away heat, vigorate qi and replenish the blood, enriching yin and nourishing kidney, warming YANG nourishing YIN, activating blood circulation to dissipate blood stasis are arranged.So clinical prescription is more, clinical practice is more loaded down with trivial details, so a kind of various method of treatment of clinical needs are taken into account and the novel prescription of tool blood sugar reducing function.
Summary of the invention
At the clinical characters of diabetic retinopathy, the object of the present invention is to provide a kind of new medicine that can effectively treat and delay disease progression and have blood sugar reducing function.
Solution of the present invention be the utilization theory of Chinese medical science to the treatment of diabetes principle, and in conjunction with the understanding of modern medicine to diabetic retinopathy, selection can reach treatment and what delay the PD purpose is that raw material is made with Radix Panacis Quinquefolii and Chinese medicine.Technical scheme of the present invention is Radix Panacis Quinquefolii, Chinese medicine
The specific embodiment
The invention provides a kind of medicine for the treatment of and delaying diabetic retinopathy progress, it contains the medicament that the feedstock production of Radix Panacis Quinquefolii forms at least.
In the raw material, except that Radix Panacis Quinquefolii, wherein also contain the Chinese medicine Radix Puerariae, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Radix Puerariae 1-20 part.
Or except that Radix Panacis Quinquefolii, also containing the Chinese medicine Rhizoma Chuanxiong, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Rhizoma Chuanxiong 1-20 part.
Or except that Radix Panacis Quinquefolii, also contain the Chinese medicine Fructus Lycii, weight proportion is Radix Panacis Quinquefolii 5-20 part, Fructus Lycii 1-20 part.
Or except that Radix Panacis Quinquefolii, also contain Chinese medicine Radix Ophiopogonis, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Radix Ophiopogonis 1-20 part.
Or except that Radix Panacis Quinquefolii, also containing the Chinese medicine Radix Codonopsis, weight proportion is: 120 parts of Radix Panacis Quinquefolii 5-20 part, Radix Codonopsis.
Or except that Radix Panacis Quinquefolii, also containing salviamiltiorrhizabung, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Radix Salviae Miltiorrhizae 1-20 part.
Or except that Radix Panacis Quinquefolii, also containing the Chinese medicine Rhizoma Dioscoreae, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Rhizoma Dioscoreae 1-20 part
Or except that Radix Panacis Quinquefolii, also containing the Chinese medicine Stigma Maydis, weight proportion is: Radix Panacis Quinquefolii 5-20 part, Stigma Maydis 1-25 part
Preferred medicine of the present invention is made up of following materials of weight proportions: Radix Panacis Quinquefolii 5-20 part, Radix Puerariae 1-20 branch, Rhizoma Chuanxiong 1-20 part, Fructus Lycii 1-20 part, Radix Ophiopogonis 1-20 part, Radix Codonopsis 1-20 part, Radix Salviae Miltiorrhizae 1-20 part, Rhizoma Dioscoreae 1-20 part, Stigma Maydis 1-20 part.
Preferred medicine material weight proportion is:
20 parts in the West, Radix Puerariae 20 minutes, 20 parts of Rhizoma Chuanxiongs, 20 parts of Fructus Lycii, 20 parts of Radix Ophiopogonis, 20 parts of Radix Codonopsis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Dioscoreaes, 20 parts of Stigma Maydis.
Radix Panacis Quinquefolii is nutrition, the nourishing class medicine that introduced in recent years a kind of has multiple efficacy of drugs, discover at present have bring high blood pressure down, effects such as blood sugar lowering, blood fat reducing, arteriosclerosis.The present invention utilizes its blood pressure lowering, blood sugar lowering, resisting fatigue and adjusting central nervous system's effect, as main component.And the Chinese medicine Radix Puerariae has the effect of blood sugar lowering, promoting the production of body fluid to quench thirst, and modern medicine study can obviously be alleviated eye symptom.The effect of Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae blood-activating and qi-promoting, activating blood circulation to dissipate blood stasis helps whole body blood vessel circulation to improve.The effect that Fructus Lycii, Radix Ophiopogonis have yin nourishing, increase liquid, moisturize, Fructus Lycii is materials for improving vision also.Radix Codonopsis, Rhizoma Dioscoreae have the effect of nourishing blood to promote the production of body fluid, YIN nourishing and the production of body fluid promoting.Stigma Maydis inducing diuresis to remove edema, blood pressure lowering, blood sugar lowering.The use in conjunction of said medicine can effectively prevent the eye pathological changes that caused with diabetes-alleviating.
Analyze the progress that Radix Panacis Quinquefolii, Radix Puerariae, Rhizoma Chuanxiong, Fructus Lycii, Radix Ophiopogonis, Radix Codonopsis, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae, Stigma Maydis can the effectively preventing diabetic retinopathy from theory of medicine, can prove that by clinical trial the present invention is at the clinical good therapeutic effect of getting.
The diabetic retinopathy staging diagnosis standard of passing through in 1987 according to Society of Ophthalmology of Chinese Medical Association: select simple type I-III phase patient.
The clinical trial situation is 100 routine outpatients, age 35-70 year, wherein male 59 examples, women 41 examples.Equal routine is carried out mydriasis inspection optical fundus before the medication, continues other drug treatment diabetes during the medication.
Therapeutic scheme is that following medicine material is formed the capsule that makes:
Radix Panacis Quinquefolii 15 restrains, Radix Puerariae 10 restrains, Rhizoma Chuanxiong 10 restrains, Fructus Lycii 15 restrains, restrain Radix Ophiopogonis 10, Radix Codonopsis 10 restrains, Radix Salviae Miltiorrhizae 10 restrains, Rhizoma Dioscoreae 10 restrains, Stigma Maydis 10 restrains.
Therapeutic Method: described capsule, every day 3 times, each 5 (capsule contains medicine 0.5 gram).
Criterion of therapeutical effect: produce effects: medication after 10 days subjective symptoms obviously improve; Effectively: medication is the subjective symptoms improvement after 20 days; Invalid, after the medication after 20 days, symptom does not still have and alleviates.
Therapeutic outcome: treat 100 routine patients, 90 examples are effective, and total obvious effective rate is 90%.All the other are effective and invalid.
The present invention can realize by following manner for the effective ingredient that does not influence former spice does not destroy when processed:
Embodiment 1
Raw material is formed: Radix Panacis Quinquefolii 1kg, Radix Puerariae 1kg, Rhizoma Chuanxiong 1kg, Fructus Lycii 1kg, Radix Ophiopogonis 1kg, Radix Codonopsis 1kg, Radix Salviae Miltiorrhizae 1kg, Rhizoma Dioscoreae 1kg, Stigma Maydis 0.5kg.
Radix Panacis Quinquefolii, Radix Puerariae, Rhizoma Chuanxiong, Fructus Lycii, Radix Ophiopogonis, Radix Codonopsis, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae, Stigma Maydis with above-mentioned dosage.After the oven dry, go back oxidative ethane sterilization after, pulverize in the Capsules of packing into, can obtain the capsule that raw material is formed.
Claims (13)
1. a medicine of preventing and treating diabetic retinopathy is characterized in that, it is the medicament that is formed by the feedstock production that contains Radix Panacis Quinquefolii at least.
2. the medicine of control diabetic retinopathy according to claim 1 also contains Radix Puerariae in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Radix Puerariae 1-15 part
3. the medicine of control diabetic retinopathy according to claim 1 also contains Rhizoma Chuanxiong in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Rhizoma Chuanxiong 1-20 part.
4. the medicine of control diabetic retinopathy according to claim 1 also contains Fructus Lycii in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Fructus Lycii 1-20 part.
5. the medicine of control diabetic retinopathy according to claim 1 also contains Radix Ophiopogonis in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Radix Ophiopogonis 1-20 part.
6. the medicine of control diabetic retinopathy according to claim 1 also contains Radix Codonopsis in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Radix Codonopsis 1-20 part.
7. the medicine of control diabetic retinopathy according to claim 1 also contains Radix Salviae Miltiorrhizae in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Radix Salviae Miltiorrhizae 1-20 part.
8. the medicine of control diabetic retinopathy according to claim 1 also contains Rhizoma Dioscoreae in its raw material, weight proportion is:
Radix Panacis Quinquefolii 5-20 part, Rhizoma Dioscoreae 1-20 part.
9. according to the medicine of the described control diabetic retinopathy of claims 1-8, form by following materials of weight proportions.
Radix Panacis Quinquefolii 5-20 part, Radix Puerariae 1-20 branch, Rhizoma Chuanxiong 1-20 part, Fructus Lycii 1-20 part, Radix Ophiopogonis 1-20 part, Radix Codonopsis 1-20 part, Radix Salviae Miltiorrhizae 1-20 part, Rhizoma Dioscoreae 1-20 part, Stigma Maydis 1-20 part.
10. the medicine of control diabetic retinopathy according to claim 9, wherein each raw material weight proportioning is:
Radix Panacis Quinquefolii 5-20 part, Radix Puerariae 5-20 branch, Rhizoma Chuanxiong 5-20 part, Fructus Lycii core 5-20 part, Radix Ophiopogonis 5-20 part, Radix Codonopsis 5-20 part, Radix Salviae Miltiorrhizae 5-20 part, Rhizoma Dioscoreae 5-20 part, Stigma Maydis 5-20 part.
11. the medicine of control diabetic retinopathy according to claim 10, wherein each raw material weight proportioning is:
20 parts of Radix Panacis Quinquefoliis, Radix Puerariae 20 minutes, 20 parts of Rhizoma Chuanxiongs, 20 parts of Fructus Lycii, 20 parts of Radix Ophiopogonis, 20 parts of Radix Codonopsis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Dioscoreaes, 15 parts of Stigma Maydis.
12., it is characterized in that said medicament is a said dosage form on any pharmaceutics according to the medicine of the described control diabetic retinopathy of claim 1-11.
13. the medicine of control diabetic retinopathy according to claim 12 is characterized in that said dosage form is a said peroral dosage form on any pharmaceutics.
The said medicine raw material can not add sacchariferous adjuvant in acceptable technical process preparation, take to be fit to diabetics.And after former medicine drying, pulverize before, carry out oxirane disinfection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101127141A CN101322731A (en) | 2007-06-11 | 2007-06-11 | Capsule for protecting eye and lowering blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101127141A CN101322731A (en) | 2007-06-11 | 2007-06-11 | Capsule for protecting eye and lowering blood sugar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101322731A true CN101322731A (en) | 2008-12-17 |
Family
ID=40186532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101127141A Pending CN101322731A (en) | 2007-06-11 | 2007-06-11 | Capsule for protecting eye and lowering blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101322731A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599405A (en) * | 2013-10-18 | 2014-02-26 | 卞佳林 | Blood sugar-reducing pharmaceutical composition and preparation method thereof |
| CN109045213A (en) * | 2018-08-13 | 2018-12-21 | 安徽国科生物科技有限公司 | A kind of preparation method for the low deuterium-oxide drink preventing and treating diabetes |
| CN112316080A (en) * | 2020-11-18 | 2021-02-05 | 沈阳奇力生物科技有限公司 | Poultry feeding granule containing Chinese herbal medicines for reducing blood sugar |
-
2007
- 2007-06-11 CN CNA2007101127141A patent/CN101322731A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599405A (en) * | 2013-10-18 | 2014-02-26 | 卞佳林 | Blood sugar-reducing pharmaceutical composition and preparation method thereof |
| CN103599405B (en) * | 2013-10-18 | 2016-03-09 | 卞佳林 | A kind of hypoglycemic medicine composition and preparation method thereof |
| CN109045213A (en) * | 2018-08-13 | 2018-12-21 | 安徽国科生物科技有限公司 | A kind of preparation method for the low deuterium-oxide drink preventing and treating diabetes |
| CN112316080A (en) * | 2020-11-18 | 2021-02-05 | 沈阳奇力生物科技有限公司 | Poultry feeding granule containing Chinese herbal medicines for reducing blood sugar |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631558A (en) | Medicament for treating eye disease and preparation method of medicament | |
| CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
| CN101822789B (en) | Hypotensor treating essential hypertension | |
| CN102813780A (en) | Chinese herbal medicinal compound preparation used for treating macular degeneration of old people and preparation method thereof | |
| CN102302740B (en) | Preparation method of traditional Chinese medicine used for treating thoracic obstructions caused by yin deficiency of heart and kidney | |
| CN102357195B (en) | Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof | |
| CN101322731A (en) | Capsule for protecting eye and lowering blood sugar | |
| CN102512470B (en) | Pharmaceutical composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application | |
| CN102309575A (en) | Application of medicinal composition in preparing medicament for treating diabetic complication | |
| CN104248717B (en) | A kind of foot-bath traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN103301431B (en) | Traditional Chinese medicinal preparation for treating glaucoma and preparation method thereof | |
| CN102274396B (en) | Traditional Chinese medicine for treating diabetic nephropathy and preparation method thereof | |
| CN109260397A (en) | A kind of Chinese medicine composition for treating Vascular retinopathy | |
| CN102397399B (en) | Application of traditional Chinese medicinal composition in preparation of medicament for controlling diabetes complications | |
| CN102406797B (en) | Traditional Chinese medicine composition for treating palpitation | |
| CN101185723A (en) | Traditional Chinese medicine preparation for treating diabetic retina affection | |
| CN104739946A (en) | Health preserving microcapsule for preventing and treating hyperlipidemia, high blood pressure and high blood sugar | |
| CN113908235B (en) | Chinese herbal compound preparation for treating diabetic retinopathy and preparation method and application thereof | |
| CN103948880B (en) | Traditional Chinese medicine for treating arrhythmia | |
| CN102266528B (en) | Medicament for treating hypertension | |
| CN103341015B (en) | Medicine for treating three-highs and preparation method thereof | |
| CN102406924B (en) | Medicine composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application thereof | |
| CN107693621A (en) | Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment | |
| CN106177331A (en) | A kind of Chinese medicine treating hypertension | |
| CN101623378B (en) | Chinese medicament for treating high blood pressure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI GUOHUA Free format text: FORMER OWNER: LIU YANHUA Effective date: 20110322 Owner name: LIU YANHUA CHEN XIN Free format text: FORMER OWNER: CHEN XIN |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Guohua Inventor after: Liu Yanhua Inventor after: Chen Xin Inventor before: Liu Yanhua Inventor before: Chen Xin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 252201 NO. 199, BUSINESS STREET, DONG E COUNTY, LIAOCHENG CITY, SHANDONG PROVINCE TO: 252201 PEOPLE S HOSPITAL, DONG E COUNTY, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU YANHUA CHEN XIN TO: LI GUOHUA LIU YANHUA CHEN XIN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110322 Address after: 252201 Dong'e County People's Hospital of Shandong Province Applicant after: Li Guohua Co-applicant after: Liu Yanhua Co-applicant after: Chen Xin Address before: 252201 No. 199 commercial street, Dong'e County, Liaocheng, Shandong Applicant before: Liu Yanhua Co-applicant before: Chen Xin |
|
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20081217 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |